Thalidomide based drugs: price, availability and description

Thalidomide is an immunomodulatory agent with potent anti-angiogenic properties (blocks the growth of new blood vessels supplying the tumor). It is currently used under strict supervision for the treatment of newly diagnosed multiple myeloma (in combination with dexamethasone) and for the acute treatment of the cutaneous manifestations of moderate to severe erythema nodosum leprosum (ENL). It is strictly contraindicated in pregnancy due to its teratogenic effects.